Overview

Chemoembolization for Lung Tumors

Status:
Active, not recruiting

Trial end date:
2022-12-13

Target enrollment:

Participant gender:

Summary

This study is being done to determine if it is safe to perform lung chemoembolization and if the lung chemoembolization procedure can successfully deliver chemotherapy to lung tumors.

Phase:

Phase 1

Details

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Treatments:

Ethiodized Oil
Mitomycin
Mitomycins